bard_score_interpret: BARD Score for assessing Fibrosis in NAFLD Interpretation

In cliot: Clinical Indices and Outcomes Tools

BARD Score for assessing Fibrosis in NAFLD Interpretation

Description

By using a patient's bmi, lab values of aspartate transferae, alanine transferase, and whether they have type 2 diabetes, calculate the patient's risk for fibrosis, especially if they have diagnosed or suspected NAFLD. Created by Harrison et al. 2008. Validated by Ruffillo et al. (2011) and Raszeja-wyszomirska et al. (2010).

Usage

bard_score_interpret(bmi, ast, alt, diabetes)

Arguments

bmi	Numeric value of bmi (kg/m^2).
ast	Numeric value of aspartate transferase (U/L).
alt	Numeric value of alanine transferase (U/L).
diabetes	Numeric value of type 2 diabetes mellitus status yes = 1, no = 0.

Value

A string with interpreted BARD score as "high" or "low" fibrosis.

References

Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57(10):1441-7. Raszeja-wyszomirska J, Szymanik B, Ławniczak M, et al. Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol. 2010;10:67. Ruffillo G, Fassio E, Alvarez E, et al. Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011;54(1):160-3. Cichoż-lach H, Celiński K, Prozorow-król B, Swatek J, Słomka M, Lach T. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. Med Sci Monit. 2012;18(12):CR735-40.

Examples

# The function is defined as
bard_score_interpret(25, 40, 32, 1)

cliot documentation built on May 29, 2024, 11:13 a.m.